BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3458380)

  • 1. Typhlitis: selective surgical management.
    Moir CR; Scudamore CH; Benny WB
    Am J Surg; 1986 May; 151(5):563-6. PubMed ID: 3458380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful medical management of neutropenic enterocolitis (typhlitis) in a child with acute lymphoblastic leukemia.
    Ozçay F; Kayiran SM; Ozbek N
    Turk J Pediatr; 2003; 45(3):248-50. PubMed ID: 14696805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia.
    Shamberger RC; Weinstein HJ; Delorey MJ; Levey RH
    Cancer; 1986 Feb; 57(3):603-9. PubMed ID: 3484659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
    Seddon AN; Chaim J; Akin O; Drill E; Michael AG; Adel N; Tallman MS
    Leuk Res; 2018 May; 68():48-50. PubMed ID: 29544131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neutropenic enterocolitis in adults with acute leukemia].
    Uzuka Y; Saito Y; Takahashi H; Komatu M; Ito T
    Rinsho Ketsueki; 1989 Jul; 30(7):980-7. PubMed ID: 2810800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typhlitis in acute childhood leukemia.
    Wu SF; Peng CT; Tsai FJ; Tsai CH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(3):208-10. PubMed ID: 8755177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.
    Hogan WJ; Letendre L; Litzow MR; Tefferi A; Hoagland HC; Pruthi RK; Kaufmann SH
    Mayo Clin Proc; 2002 Aug; 77(8):760-2. PubMed ID: 12173711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterocolitis as initial presentation of acute myelogenous leukemia exacerbated by induction chemotherapy with idarubicin-cytosine arabinoside.
    Wood RA
    Mayo Clin Proc; 2002 Oct; 77(10):1133. PubMed ID: 12374257
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of lithium to limit neutropenia significantly during induction therapy of acute myelogenous leukemia. A Southeastern Cancer Study Group study.
    Stein RS; Vogler WR; Lefante J
    Am J Clin Oncol; 1984 Aug; 7(4):365-9. PubMed ID: 6430063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal lavage as an aid in the surgical management of neutropenic colitis.
    Geer DA; Lee YT; Barcia PJ
    J Surg Oncol; 1986 Mar; 31(3):222-4. PubMed ID: 3459943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and outcomes of enteritis, typhlitis, and colitis in children with acute leukemia.
    Shafey A; Ethier MC; Traubici J; Naqvi A; Sung L
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):514-7. PubMed ID: 23823116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of neutropenic enterocolitis (typhlitis) by ultrasonography.
    Gootenberg JE; Abbondanzo SL
    Am J Pediatr Hematol Oncol; 1987; 9(3):222-7. PubMed ID: 3314548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
    Yi HS; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
    Leuk Res; 2010 Jul; 34(7):e173-5. PubMed ID: 20074799
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
    Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
    Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index.
    Kawasaki Y; Kimura SI; Nakano H; Mashima K; Shirato Y; Kawaguchi SI; Toda Y; Ochi SI; Nagayama T; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Fujiwara SI; Ohmine K; Kako S; Muroi K; Kanda Y
    Int J Hematol; 2019 Apr; 109(4):470-476. PubMed ID: 30684252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutropenic typhlitis: a frequently missed complication of aplasia-inducing tumor therapy with a possible association to the combination of etoposide with high-dose cytosine-arabinoside].
    Benz G; Gmür J; Gubler J
    Schweiz Med Wochenschr; 1994 Feb; 124(5):186-92. PubMed ID: 8128200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultrasonographic diagnosis of typhlitis (neutropenic colitis).
    Alexander JE; Williamson SL; Seibert JJ; Golladay ES; Jimenez JF
    Pediatr Radiol; 1988; 18(3):200-4. PubMed ID: 3285305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine-arabinoside-induced colitis and peritonitis: nonoperative management.
    Johnson H; Smith TJ; Desforges J
    J Clin Oncol; 1985 May; 3(5):607-12. PubMed ID: 3873521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typhlitis in acute childhood leukemia.
    Altınel E; Yarali N; Isık P; Bay A; Kara A; Tunc B
    Med Princ Pract; 2012; 21(1):36-9. PubMed ID: 22024548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.